MedTrace Logo

GBR 12909 Study in Cocaine Experienced African American Volunteers - 1

NCT00089687 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2017-01-11

No results posted yet for this study

Summary

The purpose of this study is to assess GBR 12909 in cocaine experienced African American Volunteers.

Conditions

  • Cocaine-Related Disorders

Interventions

DRUG

GBR 12909

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    lead NIH

Principal Investigators

  • Louis Cantilena, M.D. · Uniformed Services University of Health Science

Study Design

Purpose
TREATMENT

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-04-30
Completion
2005-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00089687 on ClinicalTrials.gov